-
China to further contribute to global fight against COVID-19
chinadaily
March 16, 2020
China will further expand international cooperation and offer help to other countries and regions in their fight against the novel coronavirus disease (COVID-19), according to a commerce official on March 12.
-
Medicago produces viable Covid-19 vaccine candidate
pharmaceutical-technology
March 16, 2020
Biopharmaceutical firm Medicago has produced a Virus-Like Particle (VLP) of the novel coronavirus, marking the first step in Covid-19 vaccine development.
-
Inovio secures funds for delivery device of Covid-19 vaccine
pharmaceutical-technology
March 16, 2020
Inovio Pharmaceuticals has received a $5m grant from the Bill & Melinda Gates Foundation to support the testing and scale-up of a smart delivery device for Covid-19 vaccine, INO-4800.
-
ImmunoPrecise uses PolyTope mAb Therapy for Covid-19
pharmaceutical-technology
March 16, 2020
ImmunoPrecise Antibodies is set to use PolyTope mAb Therapy approach for the development of a universal COVID-19 therapy.
-
I-Mab Explores TJM2 in Treating Severe COVID-19 Disease
contractpharma
March 16, 2020
Clinical study will explore the potential of TJM2, a mAb against Cytokine Release Syndrome, which is an overreaction of the immune system caused by inflammation.
-
Special report highlights potential therapeutic agents, vaccines for COVID-19
worldpharmanews
March 16, 2020
Since the first reports of a new coronavirus disease in Wuhan, China, in December 2019, COVID-19 has spread rapidly across the globe, threatening a pandemic.
-
A world premiere from Erasmus MC and Utrecht University: they found an antibody against COVID-19
worldpharmanews
March 16, 2020
Since Thursday evening, the article by a team of ten scientists has been online on BioRxiv - a website where biologists can publish their research before it will be assessed ...
-
EMA announces measures to manage drug shortages as result of COVID-19
europeanpharmaceuticalreview
March 16, 2020
An EU Executive Steering Group will discuss how to address the impact of medicine shortages caused due to COVID-19, says the EMA.
-
India should reduce dependence on China for APIs, says industry insider
europeanpharmaceuticalreview
March 16, 2020
According to a report, supply disruption scares and price hikes due to COVID-19 are a ‘wake-up call’ for India to reduce its dependence on China for APIs.
-
Mallinckrodt explores iNO as potential Covid-19 therapy
pharmaceutical-technology
March 16, 2020
Mallinckrodt has started exploring inhaled nitric oxide (iNO) as a potential supportive measure for COVID-19 patients with pulmonary complications.